Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11369567 | CMP DEV LLC | Aqueous suspension suitable for oral administration |
Jun, 2037
(14 years from now) |
Market Authorisation Date: 01 February, 2023
Treatment: NA
Dosage: SUSPENSION;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic